行情

PODD

PODD

Insulet
NASDAQ

实时行情|Nasdaq Last Sale

188.76
-2.70
-1.41%
盘后: 188.76 0 0.00% 16:12 01/17 EST
开盘
190.63
昨收
191.46
最高
191.66
最低
187.10
成交量
35.95万
成交额
--
52周最高
192.43
52周最低
72.65
市值
116.69亿
市盈率(TTM)
742.56
分时
5日
1月
3月
1年
5年

分析师评级

17位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

PODD 新闻

  • Diabetes Management Gains FDA Attention: 3 Stocks in Focus
  • Zacks.21小时前
  • The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares
  • Benzinga.21小时前
  • The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics
  • Benzinga.1天前
  • Tandem Diabetes Launches a New Version of Its Insulin Pump
  • MotleyFool.com.3天前

更多

所属板块

医疗设备、用品及经销
+0.07%
医疗设备和用品
+0.29%

热门股票

名称
价格
涨跌幅

PODD 简况

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The Omnipod System features a self-adhesive disposable tubeless Omnipod device, which is worn on the body for approximately three days at a time and its wireless companion, the handheld Personal Diabetes Manager (PDM). The Omnipod System features two discreet devices that eliminate the need for a bulky pump, tubing and separate blood glucose meter, provides for virtually pain-free automated cannula insertion, communicates wirelessly and integrates a blood glucose meter. The Omnipod System is a discreet two part design, the Omnipod device (Pod) and the PDM that eliminates the need for the external tubing required with conventional pumps. The Pod is a self-adhesive device that the patient fills with insulin and wears directly on the body.
展开

Webull提供Insulet Corporation的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。